(Q42639781)

English

Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study

scientific article published on January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

based on heuristic

inferred from title

Parkinson's disease

1 reference

based on heuristic

inferred from title

Michael S. Okun

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Hubert H Fernandez

1

object named as

Hubert H Fernandez

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

author name string

Ramon L Rodriguez

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Irene A Malaty

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Janet Romrell

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Anqi Sun

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Samuel S Wu

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sandeep Pillarisetty

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Anand Nyathappa

9

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Stephan Eisenschenk

10

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

International Journal of Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

119

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

2196-2205

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Parkinson's disease and sleepiness: an integral part of PD.

1 reference

https://api.crossref.org/works/10.3109%2F00207450903222758

21 January 2018

Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations.

1 reference

https://api.crossref.org/works/10.3109%2F00207450903222758

21 January 2018

Scales to assess psychosis in Parkinson's disease: Critique and recommendations

1 reference

https://api.crossref.org/works/10.3109%2F00207450903222758

21 January 2018

Long‐term outcome of quetiapine use for psychosis among parkinsonian patients

1 reference

https://api.crossref.org/works/10.3109%2F00207450903222758

21 January 2018

Atypical antipsychotics in Parkinson-sensitive populations

1 reference

https://api.crossref.org/works/10.3109%2F00207450903222758

21 January 2018

Mortality and hallucinations in nursing home patients with advanced Parkinson's disease.

1 reference

https://api.crossref.org/works/10.3109%2F00207450903222758

21 January 2018

Quetiapine for insomnia in Parkinson disease: results from an open-label trial

1 reference

https://api.crossref.org/works/10.3109%2F00207450903222758

21 January 2018

Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.3109%2F00207450903222758

21 January 2018

Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.3109%2F00207450903222758

21 January 2018

Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.3109%2F00207450903222758

21 January 2018

Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration.

1 reference

https://api.crossref.org/works/10.3109%2F00207450903222758

21 January 2018

Pathophysiology and treatment of psychosis in Parkinson's disease: a review

1 reference

https://api.crossref.org/works/10.3109%2F00207450903222758

21 January 2018

Identifiers

10.3109/00207450903222758

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42639781&oldid=1964347598"